MiR-34c may protect lung cancer cells from paclitaxel-induced apoptosis

Oncogene

Volumn 32, Issue 3, 2013, Pages 341-351

  Catuogno, S ^a,b   Cerchia, L ^a   Romano, G ^c   Pognonec, P ^d   Condorelli, G ^a,b   De Franciscis, V ^a  

^a CNR   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c IRCCS SDN   (Italy)

^d UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

A549; AP20187; p53

Indexed keywords

CASPASE 8; MICRORNA; MICRORNA 124 1; MICRORNA 135; MICRORNA 17; MICRORNA 34C; MICRORNA 34C 5P; MICRORNA 520; PACLITAXEL; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; ONCOGENE C MYC; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BASE SEQUENCE; CASPASE 8; CELL LINE, TUMOR; HUMANS; LUNG NEOPLASMS; MICRORNAS; PACLITAXEL;

EID: 84872618414     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.51     Document Type: Article

References (45)

1. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-233.
2. Farazi TA, Spitzer JI, Morozov P, Tuschl T. miRNAs in human cancer. J Pathol 2011; 223: 102-115.
3. Garofalo M, Croce CM. MicroRNAs: master regulators as potential therapeutics in cancer. Annu Rev Pharmacol Toxicol 2011; 51: 25-43.
4. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998; 281: 1305-1308.
5. Hengartner MO. The biochemistry of apoptosis. Nature 2000; 407: 770-776.
6. Inui M, Martello G, Piccolo S. MicroRNA control of signal transduction. Nat Rev Mol Cell Biol 2010; 11: 252-263.
7. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007; 26: 745-752.
8. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y et al. A microRNA component of the p53 tumour suppressor network. Nature 2007; 447: 1130-1134.
9. Carlotti F, Zaldumbide A, Martin P, Boulukos KE, Hoeben RC, Pognonec P. Development of an inducible suicide gene system based on human caspase 8. Cancer Gene Ther 2005; 12: 627-639.
10. Chang DW, Yang X. Activation of procaspases by FK506 binding protein-mediated oligomerization. Sci STKE 2003; 167: PL1.
11. Nagel R, le Sage C, Diosdado B, van der Waal M, Oude Vrielink JA, Bolijn A et al. Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. Cancer Res 2008; 68: 5795-5802.
12. Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, Nair S et al. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 2008; 10: 202-210.
13. Corney DC, Hwang CI, Matoso A, Vogt M, Flesken-Nikitin A, Godwin AK et al. Frequent downregulation of miR-34 family in human ovarian cancers. Clin Cancer Res 2010; 16: 1119-1128.
14. Bommer GT, Gerin I, Feng Y, Kaczorowski AJ, Kuick R, Love RE et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 2007; 17: 1298-1307.
15. He X, He L, Hannon GJ. The guardian's little helper: microRNAs in the p53 tumor suppressor network. Cancer Res 2007; 67: 11099-11101.
16. Hermeking H. The miR-34 family in cancer and apoptosis. Cell Death Differ 2010; 17: 193-199.
17. Cannell IG, Bushell M. Regulation of Myc by miR-34c: a mechanism to prevent genomic instability? Cell Cycle 2010; 9: 2726-2730.
18. van Leeuwen I, Lain S. Sirtuins and p53. Adv Cancer Res 2009; 102: 171-195.
19. Chabalier C, Lamare C, Racca C, Privat M, Valette A, Larminat F. BRCA1 downregulation leads to premature inactivation of spindle checkpoint and confers paclitaxel resistance. Cell Cycle 2006; 5: 1001-1007.
20. Zachos G, Black EJ, Walker M, Scott MT, Vagnarelli P, Earnshaw WC et al. Chk1 is required for spindle checkpoint function. Dev Cell 2007; 12: 247-260.
21. Del Sal G, Murphy M, Ruaro E, Lazarevic D, Levine AJ, Schneider C. Cyclin D1 and p21/waf1 are both involved in p53 growth suppression. Oncogene 1996; 4: 177-185.
22. Sykes SM, Mellert HS, Holbert MA, Li K, Marmorstein R, Lane WS et al. Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol Cell 2006; 24: 841-851.
23. Tang Y, Luo J, Zhang W, Gu W. Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol Cell 2006; 24: 827-839.
24. Mellert HS, Stanek TJ, Sykes SM, Rauscher III FJ, Schultz DC, McMahon SB. Deacetylation of the DNA-binding domain regulates p53-mediated apoptosis. J Biol Chem 2011; 286: 4264-4270.
25. Yamakuchi M, Ferlito M, Lowenstein CJ. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci USA 2008; 105: 13421-13426.
26. Guicciardi ME, Gores GJ. Life and death by death receptors. FASEB J 2009; 23: 1625-1637.
27. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 2007; 26: 731-743.
28. Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, Menssen A et al. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 2007; 6: 1586-1593.
29. Christoffersen NR, Shalgi R, Frankel LB, Leucci E, Lees M, Klausen M et al. p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC. Cell Death Differ 2010; 17: 236-245.
30. Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med 2011; 17: 211-215.
31. Li Y, Guessous F, Zhang Y, Dipierro C, Kefas B, Johnson E et al. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res 2009; 69: 7569-7576.
32. Dacic S, Kelly L, Shuai Y, Nikiforova MN. miRNA expression profiling of lung adenocarcinomas: correlation with mutational status. Mod Pathol 2010; 23: 1577-1582.
33. Lee JH, Voortman J, Dingemans AM, Voeller DM, Pham T, Wang Y et al. MicroRNA expression and clinical outcome of small cell lung cancer. PLoS One 2011; 6: e21300.
34. Corney DC, Flesken-Nikitin A, Godwin AK, Wang W, Nikitin AY. MicroRNA-34b and microRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res 2007; 67: 8433-8438.
35. Allan LA, Clarke PR. Phosphorylation of caspase-9 by CDK1/cyclin B1 protects mitotic cells against apoptosis. Mol Cell 2007; 26: 301-310.
36. Schiff PB, Fant J, Horwitz SB. Promotion of microtubule assembly in vitro by taxol. Nature 1979; 277: 665-667.
37. Sotillo E, Laver T, Mellert H, Schelter JM, Cleary MA, McMahon S et al. Myc overexpression brings out unexpected antiapoptotic effects of miR-34a. Oncogene 2011; 30: 2587-2594.
38. Maclean KH, Keller UB, Rodriguez-Galindo C, Nilsson JA, Cleveland JL. c-Myc augments gamma irradiation-induced apoptosis by suppressing Bcl-XL. Mol Cell Biol 2003; 23: 7256-7270.
39. Cannell IG, Kong YW, Johnston SJ, Chen ML, Collins HM, Dobbyn HC et al. p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication. Proc Natl Acad Sci USA 2010; 107: 5375-5380.
40. Murphy DJ, Junttila MR, Pouyet L, Karnezis A, Shchors K, Bui DA et al. Distinct thresholds govern Myc's biological output in vivo. Cancer Cell 2008; 14: 447-457.
41. Soucek L, Evan GI. The ups and downs of Myc biology. Curr Opin Genet Dev 2010; 20: 91-95.
42. Allen TD, Zhu CQ, Jones KD, Yanagawa N, Tsao MS, Bishop JM. Interaction between MYC and MCL1 in the genesis and outcome of non-small-cell lung cancer. Cancer Res 2011; 71: 2212-2221.
43. Kress TR, Cannell IG, Brenkman AB, Samans B, Gaestel M, Roepman P et al. The MK5/PRAK kinase and Myc form a negative feedback loop that is disrupted during colorectal tumorigenesis. Mol Cell 2011; 41: 445-457.
44. Lu W, Lin J, Chen J. Expression of p14ARF overcomes tumor resistance to p53. Cancer Res 2002; 62: 1305-1310.
45. Yamakuchi M, Lowenstein CJ. MiR-34, SIRT1 and p53: the feedback loop. Cell Cycle 2009; 8: 712-715.